Refine
Year of publication
Document Type
- Doctoral Thesis (37)
- Article (36)
Has Fulltext
- yes (73)
Is part of the Bibliography
- no (73)
Keywords
- - (23)
- Streptococcus pneumoniae (10)
- Staphylococcus aureus (4)
- colonization (4)
- proteomics (4)
- CRISPR/Cas9 (3)
- Colonization (3)
- Ghana (3)
- Massenspektrometrie (3)
- Molekularbiologie (3)
- PCV13 (3)
- Proteom (3)
- Proteomics (3)
- pneumococci (3)
- <i>Streptococcus pneumoniae</i> (2)
- Endothelzellen (2)
- Gefäßmissbildung (2)
- Induzierte pluripotente Stammzelle (2)
- Infektionen (2)
- NGS (2)
- Organoid (2)
- Pneumolysin (2)
- Proteomanalyse (2)
- Saccharomyces cerevisiae (2)
- Transkriptomanalyse (2)
- Vaccine (2)
- antibiotic resistance (2)
- cell signaling (2)
- infection (2)
- pathogenesis (2)
- platelets (2)
- pneumococcal carriage (2)
- pneumolysin (2)
- pneumonia (2)
- respiratory infection (2)
- serotypes (2)
- two-component system 09 (2)
- virulence (2)
- virulence genes (2)
- 3,5-Diiodthyronin (3,5-T2) (1)
- <i>Staphylococcus aureus</i> (1)
- <i>Streptococcus pyogenes</i> (1)
- ASFV (1)
- Activator-binding domain (1)
- Adherenc (1)
- Akt (1)
- Alzheimer (1)
- Antigenpräsentation (1)
- Antisense-Transkription (1)
- Apoptose (1)
- Apoptosis (1)
- ArcT peptidase (1)
- Arenaviren (1)
- Arenavirus (1)
- BH3-only proteins (1)
- BVDV (1)
- Baboon (1)
- Bacillus subtilis (1)
- Bacterial infection (1)
- Bakterien (1)
- Bdf1 (1)
- Bicyclomycin (1)
- Blut (1)
- CCM (1)
- CD4 (1)
- CNV analyses (1)
- CRISPR (1)
- CRISPR/Cas-Methode (1)
- CRISPR/Cas9-Methode (1)
- Cell culture (1)
- Cell surface molecules (1)
- Cerebral cavernous malformations (1)
- Chimpanzee (1)
- Chromosome 7q31-q36 (1)
- Co-infections (1)
- Coactivator (1)
- Communication abilities (1)
- Complement (1)
- Corepressor (1)
- Cortex (1)
- Cyc8 (1)
- Deletion mutants (1)
- Dendritic cells (1)
- Dezidua (1)
- Dissemination (1)
- Dissertation (1)
- ERK1/2 (1)
- Endothelzelle (1)
- Epilepsie (1)
- Essential Oil (1)
- Gene expression (1)
- Gene repression (1)
- Genregulation (1)
- Guanylatzyklase (1)
- Guanylatzyklasestimulator (1)
- Heart (1)
- Herz (1)
- Herzinsuffizienz (1)
- Human Oral Microbiome (1)
- Human thrombospondin-1 (1)
- Hydrogen peroxide (1)
- ILC (1)
- IR-induced variants (1)
- IRAK-M (1)
- IVIG (1)
- Immunogenicity (1)
- Immunoglobulin G (1)
- Immunologie (1)
- Inflammasome (1)
- Influenza A virus (1)
- Interaction specificity (1)
- Junin virus (1)
- Kommensale (1)
- LC-MS/MS (1)
- LL-37 (1)
- Lactoperoxidase (1)
- Language evolution (1)
- Linker Ventrikel (1)
- Lipoprotein (1)
- Lipoproteine (1)
- Listerine (1)
- Long-Read Sequenzierung (1)
- Lunge (1)
- Lymphozyt (1)
- M protein (1)
- MLST 5 (1)
- MMP-9 (1)
- Makrophage (1)
- Marmoset (1)
- Mass spectrometry (1)
- Maus (1)
- Metaproteomics (1)
- Microbiome (1)
- Mikrobiom (1)
- Molecular biology (1)
- Nervensystem (1)
- PI3K (1)
- Pankreatitis (1)
- Paraffin Gum (1)
- Pathogenität (1)
- Plasma (1)
- Plasma proteomics (1)
- Plazenta (1)
- Pneumococci (1)
- Pneumokokken (1)
- Pneumonia (1)
- Protection (1)
- Proteome (1)
- RHDV (1)
- RNA-Sequenzierung (1)
- Rabies (1)
- Rabies virus (1)
- Regulation (1)
- Repressor (1)
- Respiratory infection (1)
- Riociguat (1)
- S. aureus (1)
- S. pneumoniae (1)
- SIRS (1)
- SLC22A9 (1)
- SNVs (1)
- SP3 (1)
- SaeRS (1)
- Salivette (1)
- Schilddrüse (1)
- Schilddrüsenhormon (1)
- Schilddrüsenhormon-Metabolite (1)
- Sequenzanalyse (1)
- Sequenzierung (1)
- Serine proteases (1)
- Serotype-independent (1)
- SigB (1)
- Sin3 (1)
- Speichel (1)
- Sputum (1)
- Stammzelle (1)
- Streptococcus pneumoniae 1 (1)
- Streptococcus pyogenes (1)
- T cell receptor beta locus (1)
- TAC (1)
- TFIIA (1)
- THP-1 cells (1)
- Tacaribe virus (1)
- Teichonsäuren (1)
- Tg4-42 (1)
- Thrombozyt (1)
- Toa1 (1)
- Tollwut (1)
- Tollwutvirus (1)
- Toxin (1)
- Transkriptionstermination (1)
- Transkriptom (1)
- Tup1 (1)
- Twins (1)
- Two component systems (1)
- Two-component system (1)
- VEGF (1)
- Vakzin (1)
- Viral Vector (1)
- Virus (1)
- Vitronectin (1)
- Zahnbelag (1)
- Zahnmedizin (1)
- Zellkultur (1)
- Zerebrale Kavernöse Malformationen (1)
- Zoonose (1)
- Zunge (1)
- Zweikomponentensystem (1)
- Zwilling (1)
- adaptation (1)
- adenine nucleotide translocase 1 (1)
- adherence (1)
- adhesin A (1)
- aging (1)
- angeborene lymphoide Zellen (1)
- anti-phagocytic activity (1)
- antibiotic susceptibility 4 (1)
- antigen presentation (1)
- antimicrobial peptide (1)
- antisense RNA (1)
- bacterial cell disruption (1)
- bacterial dissemination (1)
- bacterial meningitis (1)
- blood outgrowth endothelial cells (1)
- breast cancer (1)
- cGMP signaling (1)
- capsule (1)
- carbohydrate metabolism (1)
- cardioprotection (1)
- cerebral cavernous malformation (1)
- cerebral cavernous malformations (1)
- cerebral hemorrhage (1)
- children (1)
- competence, oligopeptide (1)
- daidzein (1)
- dendritic cells (1)
- endocarditis (1)
- endothelial cells (1)
- erblich bedingte Krankheit (1)
- estrogen receptor (1)
- estrone sulfate transporter (1)
- fetal tolerance (1)
- gel-free mass spectrometry (1)
- genistein (1)
- glucose uptake (1)
- group A streptococcus (1)
- group B streptococcus (1)
- heat shock protein 27 (1)
- hemolysin (1)
- hiPSCs (1)
- host-pathogen interaction (1)
- human association studies (1)
- human breast milk (1)
- human cell lines (1)
- hyperthyroidism (1)
- iPSC (1)
- immune response,European bats,Lyssaviruses (1)
- immune responses (1)
- immunogenicity (1)
- immunomodulatory proteases (1)
- immunosenescence (1)
- in vivo virulence (1)
- innate immunity (1)
- innate lymphoid cells (1)
- internalization (1)
- invasive pneumococcal disease (1)
- label-free quantification (1)
- label-free quantitation (1)
- leukocidins (1)
- lipoprotein (1)
- mast cell (1)
- metabolism (1)
- miRNA transcriptome (1)
- miRNA-Seq (1)
- microRNA-Sequenzierung (1)
- microbiome (1)
- mitochondria (1)
- mouse model (1)
- multidrug-resistance (1)
- mutation correction (1)
- myocardial infarction (1)
- natural products (1)
- necrotizing soft tissue infections (1)
- neural induction (1)
- non-PCV13 serotypes 2 (1)
- novel (1)
- organoid (1)
- osmostress protectants (1)
- osteoporosis (1)
- p38 (1)
- peptidome (1)
- phagocytosis (1)
- pigment (1)
- platelet (1)
- pneumococcal infection (1)
- pneumococcal proteins (1)
- pneumococcal serine protease (1)
- pore-forming toxins (1)
- proinflammatory cytokines (1)
- prostate cancer (1)
- protection (1)
- radiation doses (1)
- repair mechanism (1)
- resistance genes (1)
- sea urchins (1)
- secreted virulence factors (1)
- seizures (1)
- serine proteases (1)
- sex steroids (1)
- skin infections (1)
- small cell numbers (1)
- soy isoflavones (1)
- storage conditions (1)
- streptococcal infection (1)
- streptococci (1)
- stress response (1)
- structural variation (1)
- structure (1)
- superantigens (1)
- temperature (1)
- thioglucoside conjugates (1)
- toll-like receptor 4 (1)
- topological associating domains (1)
- toxins (1)
- transcript analyses (1)
- transgenic mouse model (1)
- transition transversion ratio (1)
- translocation (1)
- transmission (1)
- tregs (1)
- vaskuläre Organoide (1)
- virulence factor (1)
- virulence genes 3 (1)
- virus (1)
- zoonosis (1)
- α‐hemolysin (1)
Institute
- Interfakultäres Institut für Genetik und Funktionelle Genomforschung (MNF) (73) (remove)
Publisher
- Frontiers Media S.A. (14)
- MDPI (13)
- S. Karger AG (4)
- Springer Nature (2)
- Wiley (2)
Bats (Chiroptera) form the second largest order of mammals and with over 1,250 species, they represent about 20% of all mammalian species worldwide. They are the only mammals with true and sustained flight and distributed all over the world except the arctic regions. Moreover, bats entered specific ecological niches and with their food spectra, they reduce different arthropod populations as well as disperse seeds and pollen of plant species in various regions and habitats.
Bats also have a crucial role in spreading high-pathogenic and zoonotic viruses, harbor in general more viruses (zoonotic and non-zoonotic), and, related to the species, number even more than rodents. However, clinical symptoms of viral diseases are rarely reported in bat communities. Also seroconversions after infection were not reported for a variety of viruses found in bats. Since the incidence of virus-positive bats estimated in passive surveillance studies is usually very low, it is a question how such viruses can use bats as reservoir hosts. There is obviously a special evolutionary relationship between the pathogens and bats as hosts, which are based on possibly physiologic adaptations also in resistance and immunity.
In this thesis, the two lyssaviruses, European Bat Lyssavirus 1 and 2 (EBLV-1 and -2) were chosen as a model to investigate the immune response of European bats against viral infection in vitro. Lyssaviruses are the causative agents of rabies, a fatal zoonotic disease with neurotropic characteristics.
One main question to investigate was in which way bats act as reservoir host and developed a high disease resistance. The present thesis is based on three hypotheses about innate immune response against lyssavirus infection:
A) In bats specific peripheral resistance mechanisms evolved which reduce the risk of systemic viral infection after a hypothesized airborne transmission and infection via nasal epithelium supported by the social structure of and communication within bat communities.
B) The co-evolution of EBLV and the innate resistance of bats resulted in a very effective type I interferon response to inhibit a systemic lyssavirus infection.
C) The specific physiology of body temperature of bats with daily torpor depresses the viral replication but favours the type I interferon response.
To analyze the interferon-based resistance mechanisms, the type I interferon (IFN) genes of two European bats species (Eptesicus serotinus and Myotis myotis) were cloned and sequenced. Using established cell lines from the respiratory nasal epithelium (MmNep), olfactory nasal epithelium (MmNol), and Bulbus olfactorius brain (MmBr), the type I IFN response along a possible airborne infection route was investigated. The anti-viral effects and induction of IFNs/interferon stimulated genes (ISGs) in each cell line were also investigated in detail after infection in vitro. Finally, the influence of different temperatures on lyssavirus replication was analyzed in cell culture experiments.
The results indicated that (a) along the hypothesized airborne infection route the susceptibility for lyssavirus infections is decreased, (b) the type I IFN activity in contrast is increased contributing to a limitation of lyssavirus replication and (c) an obvious influences of varying cultivation temperatures on the resistance against lyssavirus infections, which favor the IFN response and repressing lyssavirus replication.
The result from these in vitro studies supports the hypothesis of a special co-evolution between lyssaviruses and bats. However, in vivo studies on the relevance in infected animals are missing so far. This model could also explain the generally limited pathogenicity of bat-associated viruses.
Cardiovascular diseases are the most common cause of death in industrial nations. The basis of these diseases is a dysfunction in the interaction between the cells the heart is composed of. The main types of cells making up the human heart are cardiomyocytes that build the myocardium and provide the contraction properties, endothelial cells that delimit the blood flowing through the inner chambers and coronary arteries from the myocardial tissue, and fibroblasts, which build the connective tissue. A common process in the development of cardiovascular diseases is the formation of fibrosis due to injury of the endothelium and subsequent infiltration of the cardiac tissue by immune cells, and inflammatory agents like cytokines. Cytokines exert different functions in cardiac cells. Tumor necrosis factor α (TNFα) is an inducer of apoptosis. Transforming growth factor ß (TGFß) is known for activation of proliferation. Other cytokines like C-X-C motif chemokine 11 (CXCL11), interleukin-6 (IL-6), or brain-derived neurotrophic factor (BDNF) have not yet been investigated or their impact on such cells is unknown. Eventually, however, fibrotic scar tissue arises from the transition from fibroblasts to myofibroblasts leading to a stiffening of the cardiac muscle and impaired pump function. In order to prevent the occurrence of these events the balance of proliferation, migration, and differentiation of cardiac cells needs to be controlled very delicately.
The mechanisms controlling these interactions are still not well understood, which is why this work aimed at the elucidation of molecular mechanisms within the three main cell types that might play a role in the regulation of cardiac function. A proteomic approach using mass spectrometry was used to identify alterations in protein levels that could provide hints about the involved pathways and find new players as candidates for more detailed investigation. Initially, the proteomic composition of HL-1 cardiomyocytes, L929 fibroblasts, and human umbilical vein endothelial cells (HUVECs) that were cultivated in standard growth conditions without stress was investigated. Half of the total protein intensity was made up by only 42 to 53 proteins, depending on the cell type. More than a third of all proteins were identified in all three cell types, which may be proteins performing common cell functions. Indeed, the proteins displaying the highest abundance seem to be predominantly involved in such common cellular functions as the regulation of glucose metabolism or the cytoskeleton. More specific functions like heart development and muscle contraction were found enriched in cardiomyocytes as were mitochondrial proteins. The proportion of proteins with extracellular localization and function was higher in fibroblasts and endothelial cells.
Secondly, the impact of cytokines on the proliferative behavior and the proteomic composition of cardiomyocytes and fibroblasts was analyzed. HL-1 cardiomyocytes and L929 fibroblasts were treated with different concentrations of cytokines with a cytotoxic, proliferative, or yet unknown effect on these cells. While HL-1 cells exhibited no macroscopic reaction to any of the cytokines used, cytotoxic/growth inhibitory (TNFα, CXCL11) and proliferative (TGFß, IL6, BDNF) effects were observed for L929 cells. The latter also showed CXCL11-induced upregulated EIF2 signaling, pointing to a higher need of protein synthesis.
The third aim was the examination of proteome adaptations in endothelial cells due to different kinds of stress, as these cells are the first line of defense against inflammatory agents or injury and therefore prone to wounding. The role of the growth factors vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in wounding and starvation was another object of this study as they are known for their angiogenic and cell survival supporting properties. Additionally, the impact of the cellular sex on the response to stress and growth factors was examined, because a person’s sex plays an important role in susceptibility, risk factors, and outcome of cardiovascular diseases. This has mainly been attributed to the different hormone levels, especially the higher levels of estrogen in premenopausal women, which exerts cardioprotective properties, but also genetic background was reported to play an important role. Only few studies that examined the molecular properties of HUVECs considered the cellular sex and if so, the genetic bias of unrelated samples was not taken into account. This is why Lorenz and colleagues at the Charité in Berlin collected HUVECs from newborn twins of opposite sex, cultivated them without stress in standard growth medium, exposed them to wounding and serum starvation, and investigated the impact of the growth factors and the sex on migrational behavior and metabolic issues. The current work focused on the alterations of not only the intra- but also the extracellular proteome, because paracrine signaling is crucial for intercellular communication in order to cope with stress. General differences between male and female cells were observed for proteins encoded on the X chromosome with higher levels in females (DDX3X, UBA1, EIF1AX, RPS4X, HDHD1), except for one protein with higher levels in male cells (G6PD). A Y-chromosomal protein was, for the first time, identified in endothelial cells (DDX3Y). Wounding, starvation, and growth factor treatment led to alterations and sex-specific different levels in an unexpectedly high number of proteins, with VEGF showing a stronger impact than bFGF. Many proteins with alterations observed without taking the sex into account, were actually only changed in male or female cells. Some proteins were regulated in opposite directions, or growth factors inhibited their secretion in a sex-specific way by unknown mechanisms. Tissue factor pathway inhibitor 2 (TFPI2) should be emphasized as a protein with sex-specific differences, especially in the extracellular space and with increased levels after starvation and VEGF treatment. These observations suggest a temporal lack in TFPI2 synthesis and secretion in male cells, which might explain the enhanced adaptation of females to wounding.
The results of this work lay the basis for future investigation by providing a database of intra- and extracellular proteome changes due to different environmental circumstances. It strongly suggests the investigation of male and female HUVECs, and other cells, separately to avoid the impact of the sex observed in this work. Essentially, the observations suggest a number of candidate proteins for more detailed investigations of endothelial and cardiovascular diseases.
Untersuchungen zur Immunantwort gegen potenzielle Vakzinkandidaten von Streptococcus pneumoniae
(2022)
Das Gram-positive Bakterium Streptococcus pneumoniae (Pneumokokken) stellt vor allem bei der sehr jungen und älteren sowie immungeschwächten Bevölkerung einen immer mehr an Bedeutung gewinnenden Krankheitserreger dar. Krankheitsbilder wie die Pneumokokken-Meningitis, -Pneumonie und -Sepsis, um nur einige zu nennen, können z.T. schwere Verläufe nehmen. Neue Serotyp-unabhängige Impfstoffe sollen flächendeckenden Schutz vor Infektionen mit S. pneumoniae bieten. Das Hauptaugenmerk der Impfstoffforschung liegt unter anderem auf der Untersuchung von Pneumokokken Protein-basierten Impfstoffen als Bestandteil eines Konjugat- bzw. Multikomponenten Impfstoffes. In diesem Zusammenhang wurde in dieser Arbeit die Immunantwort humaner Immunzellen gegenüber den vier Pneumokokken Oberflächen-Lipoproteinen MetQ, DacB, PnrA und PsaA untersucht. Diese Lipoproteine wurden sowohl in lipidierter als auch in nicht-lipidierter Form als heterologe Proteine generiert, um den Einfluss der Lipidierung auf die Immunreaktion beurteilen zu können. Zur Untersuchung der Reaktion des menschlichen Immunsystems wurden humane Blut-Monozyten (hPBMCs) isoliert und zu pro-inflammatorischen Makrophagen (M1) einerseits und anti-inflammatorischen Makrophagen (M2a) andererseits differenziert. Die Zellen wurden mit den lipidierten bzw. nicht-lipidierten Proteinen stimuliert. In den Überständen wurden zur Beurteilung der abgelaufenen Immunreaktion die Konzentrationen von IL-1β, IL-2, IL-6, IL-8 und TNF bestimmt. Eine Produktion von IL-1β und IL-2 durch die Makrophagen konnte hierbei nicht nachgewiesen werden. M1 Makrophagen zeichneten sich durch eine kaum messbare Cytokin-Produktion auf beide Proteinstimuli aus. Anti-inflammatorische Makrophagen zeigten eine signifikant verstärkte IL-6, IL-8 und TNF Produktion (p< 0,05) nach Stimulation mit allen vier lipidierten Proteinen im Gegensatz zur Stimulation mit nicht-lipidierten Proteinen. Das stärkere Stimulationspotenzial der lipidierten Proteine konnte auf deren Agonismus am TLR2 zurückgeführt werden. Weiterhin konnte die starke Reaktion der M2a Makrophagen mit deren Plastizität sowie mit dem Potenzial von Lipoproteinen zur Umpolarisation von Makrophagen aufgrund des TLR2 Agonismus erklärt werden. Die Ergebnisse zeigen, dass die eingesetzten lipidierten Proteine einen suffizienten und signifikant potenteren Immunstimulus im menschlichen Organismus darstellen, als die gleichen Proteine in nicht-lipidierter Form. Somit könnten diese lipidierten Proteine geeignete Vakzinkandidaten gegen S. pneumoniae darstellen.
In den letzten Jahren gewannen ω-Transaminasen zunehmend an Bedeutung. Ihr breites Substratspektrum, das sowohl Aminosäuren als auch Amine umfasst, macht sie interessant für biotechnologische Anwendungen. Im Gegensatz zu α-Aminotransferasen sind ω-Aminotransferasen nicht auf α-Aminosäuren als Aminodonor bzw. α-Ketosäuren als Aminoakzeptoren beschränkt. Auch sind einige ω-Transaminasen in der Lage, Aldehyde oder Ketone zu aminieren. Dadurch sind sie vielseitig einsetzbar. Seit ihrer Entdeckung wurden ω-Transaminasen in einer Vielzahl von Organismen nachgewiesen. Viele dieser Enzyme stammen aus Pilzen und Bakterien. Da es ständig Bedarf an neuen Transaminasen gibt, wurden verschiedene Organismen auf das Vorhandensein solcher Enzyme untersucht. Die Hefe Blastobotrys raffinosifermentans LS3 ist einer dieser Organismen. Für diese Hefe existiert bereits eine Vielzahl biotechnologischer Anwendungen, was unter anderem an ihren vielseitigen physiologischen Möglichkeiten liegt. Um das Spektrum dieses Stammes noch zu erweitern, wurde sein Genom auf ORFs gescannt. Die ermittelten ORFs wurden translatiert und die so erhaltenen, theoretischen Proteine in einer Proteindatenbank gespeichert. Die Einträge dieser Datenbank wurden einem „hmmerscan“ (hmm ist kurz für „hidden Markov model“) unterzogen. Dabei werden die Proteine in sogenannte Pfams, kurz für Proteinfamilien, eingeteilt. Drei Proteine wurden der Familie PF00202.21 zugeordnet. Das ist die sogenannte Aminotran_3 Familie. In dieser Familie befinden sich eukaryotische ω-Transaminasen. Die Gene brota1, brota2 und brota3 codieren für diese Enzyme. Jeweils eins der Gene wurde in den Vektor XPLOR®3 kloniert, damit die potentiellen ω-Transaminasen in B. raffinosifermentans G1212 [aleu2 atrp1:ALEU2] [1] überexprimiert werden können. Eine Besonderheit von BroTA1 ist, dass es neben der Aminotran_3 Domäne noch eine AAA Domäne aufweist. Deshalb ist es mit etwa 85 kDa auch deutlich größer als die meisten ω-Transaminasen, die meist zwischen 45 und 50 kDa liegen. BroTA2 und BroTA3 beinhalten nur die Aminotran_3 Domäne. Alle drei Enzyme zeigen niedrige Aktivität bei der kinetischen Auflösung racemischer β-Aminosäuren.
Neben den eukaryotischen ω-Transaminasen wurden auch einige bakterielle Enzyme untersucht. Literatursuche und das Screenen der Stammsammlung der Arbeitsgruppe Hefegenetik des Leibniz-Instituts für Pflanzengenetik und Kulturpflanzenforschung führten zu mehreren potentiellen bakteriellen ω-Transaminasen. Das zu Beginn dieser Arbeit noch als hypothetisches Protein bezeichnete Enzym von Variovorax boronicumulans hat sich als ω-Transaminase herausgestellt. Das Enzym wurde detailliert hinsichtlich des Substratspektrums und seiner biochemischen Eigenschaften charakterisiert. Es handelt sich hierbei um eine ω-Transaminase mit β-Aktivität. Diese Transaminase akzeptiert sowohl aromatische als auch aliphatische β-Aminosäuren als Substrat. Sequenzvergleiche dieses Enzyms mit anderen ω-Transaminasen, die nur aliphatische Aminosäuren akzeptieren, führten zu tieferen Einblicken in konservierte Bereiche dieser beiden Gruppen von ω-Transaminasen.
Der dritte Ansatz war das Anpassen einer bekannten ω-Transaminase des thermophilen Bakteriums Sphaerobacter thermophilus an ein potentielles Motiv für aromatische ω-Transaminasen. Dadurch sollte die Aktivität des Enzyms erhöht werden. Dieser Ansatz führte zu 7 Varianten des Enzyms mit höherer Aktivität als der Wildtyp. Durch diese Versuche wurden einige für die Transferaseaktivität wichtige Aminosäurereste offenbart. So hat sich zum Beispiel herausgestellt, dass N70 offenbar wichtig für den Umsatz von γ-Aminosäuren ist, da ein Austausch gegen Glutamat zu einer verminderten Aktivität mit γ-Aminopentansäure führte.
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
(2018)
Streptococcus pneumoniae is endowed with a variety of surface-exposed proteins representing putative vaccine candidates. Lipoproteins are covalently anchored to the cell membrane and highly conserved among pneumococcal serotypes. Here, we evaluated these lipoproteins for their immunogenicity and protective potential against pneumococcal colonisation. A multiplex-based immunoproteomics approach revealed the immunogenicity of selected lipoproteins. High antibody titres were measured in sera from mice immunised with the lipoproteins MetQ, PnrA, PsaA, and DacB. An analysis of convalescent patient sera confirmed the immunogenicity of these lipoproteins. Examining the surface localisation and accessibility of the lipoproteins using flow cytometry indicated that PnrA and DacB were highly abundant on the surface of the bacteria. Mice were immunised intranasally with PnrA, DacB, and MetQ using cholera toxin subunit B (CTB) as an adjuvant, followed by an intranasal challenge with S. pneumoniae D39. PnrA protected the mice from pneumococcal colonisation. For the immunisation with DacB and MetQ, a trend in reducing the bacterial load could be observed, although this effect was not statistically significant. The reduction in bacterial colonisation was correlated with the increased production of antigen-specific IL-17A in the nasal cavity. Immunisation induced high systemic IgG levels with a predominance for the IgG1 isotype, except for DacB, where IgG levels were substantially lower compared to MetQ and PnrA. Our results indicate that lipoproteins are interesting targets for future vaccine strategies as they are highly conserved, abundant, and immunogenic.
Immunogenicity and protectivity of surface-localized lipoproteins of Streptococcus pneumoniae
(2019)
Steptococcus pneumoniae (pneumococcus) represents a common colonizer of the human upper respiratory tract (URT). However, under certain conditions, for example following viral infections, or in indiciduals with a weakened immune system, including young children, elderly and immunocompromised persons, it can cause a wide range of life-threatening diseases, such as pneumonia, meningitis or sepsis. Based on the polysaccharide capsule that surrounds the bacterium, pneumococci are classified into so far 98 different serotypes. Prevention of S. pneumoniae infections was achieved by the development of pneumococcal polysaccharide-based (PPSV) vaccines. However, these vaccines have important limitations, including high manufacturing costs and restricted serotype coverage facilitating replacement by non-vaccine serotypes. Aiming for the development of a serotype-independent vaccine, the potential of surface-exposed and highly conserved pneumococcal lipoproteins was evaluated for being targeted as a future protein-based vaccine. Therefore, selected lipoproteins were examined i) for their surface abundance and accessibility, ii) for their presence in clinically relevant S. pneumoniae strains, and iii) for their immunogenicity. Finally, based on these initial screenings, the most promising candidates were selected to analyze their protective efficacy in a moude model of colonization. DacB and PnrA were identified as highly abundant lipoproteins on the pneumococcal surface. They showed to be immunogenic both during natural infection using convalescent patient sera and when given to mice as a subunit vaccine formulation. Following intranasal immunization and challenge of mice with two heterologous S. pneumoniae strains, both proteins reduced the pneumococcal load in the nasopharynx. The protection correlated with increased production of IL-17A indicative for a Th17-mediated immunity, which is strongly suggested to play a critical role in preventing pneumococcal colonization and infection. Lipoproteins are triggering innate receptors on antigen-presenting cells, thereby linking innate with adaptive immune responses. Therefore, lipidated proteins were evaluated for their potential to be used as an adjuvant for vaccination. Lipidation clearly enhanced humoral immune responses to DacB and PnrA without the need of an additional adjuvant. However, an additional adjuvant was required to confer protection against pneumococcal colonization. In conclusion, Lipoproteins are interesting candidates for future protein-based vaccine strategies because they are highly conserved, abundant and immunogenic. PnrA and DacB were identified as potential candidates, since they induced protection against pneumococcal colonization, which in turn may lead to a decline in infections and transmission.
Geistige Behinderung ist eine der häufigsten Formen von erblich bedingten kognitiven Beeinträchtigungen. Definiert wird sie durch einen Intelligenzquotienten unter 70 und obwohl ihre genetischen Ursachen sehr heterogen sein können, gibt es unter ihnen eine beachtliche Menge Gene, die am Aufbau der Glycocalyx beteiligt sind [1, 2]. Die Glycocalyx besteht aus Zuckerbausteinen, die Teil von Lipiden und Proteinen der Zelloberfläche oder der extrazellulären Matrix sind. Vor kurzem konnten wir belegen, dass Mutationen im ST3GAL3-Gen, welches für die Golgi-lokalisierte β-Galactosid-α2,3-sialyltransferase-III codiert, zu verschiedenen klinischen Befunden führt. Zwei unabhängige Mutationen (p.Ala13Asp and p.Asp370Tyr), gefunden in iranischen Familien, konnten mit relativ milden Formen nicht-syndromaler geistiger Behinderung (NSARID) in Verbindung gebracht werden [5]. Eine dritte Punktmutation (p.Ala320Pro), gefunden in einer palästinensischen Familie, verursachte hingegen eine schwere, altersabhängige epileptische Enzephalopathie, das West-Syndrom. Dieses Syndrom ist mit einem Arrest der geistigen Entwicklung oder sogar, wie in unserem Fall, einer Regression assoziiert [3, 4]. ST3GAL3 bildet im Menschen unter anderem das Sialyl Lewis-a (sLea)-Epitop auf Proteinen. Exogene Expression der Volllängen-c-MYC-Fusionsproteine, der Mutationsvarianten in LMTK—Zellen, zeigte, dass alle Varianten eine gestörte subzellulare Lokalisierung zeigen und zwei von ihnen (p.Ala13ASp und p.ALA320Pro) kaum mehr messbare Aktivität besitzen [5]. Um die molekularen und zellulären Mechanismen näher zu beleuchten, die dem ST3GAL3-bedingten West-Syndrom zugrunde liegen, haben wir erfolgreich ein patientenspezifisches, induzertes pluripotentes Stammzellmodell etabliert. Hierfür wurden Fibroblasten der Patientin, die eine Mutation im Exon 12 (c.958G>C, p.Ala320Pro) des ST3GAL3-Gens trägt, und einer gesunden Schwester mittels eines lentiviralen Vektorsystems reprogrammiert. Da ST3GAL3 die höchsten Expressionswerte im frontalen Kortex zeigte, und dies auch in Übereinstimmung mit dem vorgeschlagenen Ursprung epileptischer Anfälle steht, wurde ein Differenzierungsprotokoll für kortikale Neuronen etabliert und erfolgreich für beide Zelllinien durch geführt. Einer der größten Vorteile dieses Protokolls ist, dass hier die Neurogenese in vitro nach demselben temporalen Muster abläuft wie die Neurogenese in vivo. Die iPSC und die daraus differenzierten Neuronen wurden anschließend mittels Lectinblot, mRNA-Sequenzierung, Adhärenzassays und FACS untersucht. Während keine Unterschiede zwischen den iPSC und den Fibroblasten festgestellt wurden, konnten für die kortikalen Neuronen der Patientin eine zusätzliche Bande im Lektinblot (70 kDa), ein verändertes Adhärenzverhalten auf poly-L-Orinithin/Laminin-beschichteter Oberfläche und eine deutlich reduzierte Menge T-box-transcription factor-brain-1-exprimierende Neuronen festgestellt werden. Unsere Ergebnisse zeigen, dass die ST3GAL3-Aktivität wichtig für die normale Entwicklung und Funktion des Gehirns ist.
During infections, innate immune cells are crucial for initiating a pro-inflammatory immune response and clearing the invading pathogen. Delay in pathogen clearance or initiation of an immune response due to impaired functionality of immune cells can result in devastating consequences. The cellular compartment of the innate immune system comprises an array of specialized cell types: Macrophages are tissue-resident professional phagocytes that clear cellular debris, pathogens, and foreign objects. Dendritic cells (DCs) are immune sentinels specialized in antigen uptake and subsequent T cell priming. They are primary sources of cytokines in response to infection. Neutrophils are efficient effector cells that respond rapidly to infection and clear bacteria by different mechanisms. If effector mechanisms of these cells are affected by either bacterial or other factors, infections might not be resolved and can spread throughout the host. Cobalt-chromium-molybdenum biomaterial is widely used in arthroplasty. Implant-derived wear particles and ions lead to macrophage-driven adverse local tissue reactions: Such reactions have been linked to an increased risk of periprosthetic joint infection after revision arthroplasty. While metal-induced cytotoxicity is well characterized in human macrophages, direct effects on their functionality remain elusive. In Paper I, we show that local peri-implant tissue is exposed to Co and Cr in situ. Influx of macrophages is also evident. Exposure of isolated human monocytes/macrophages to Cr3+ in vitro had only minor effects. However, exposure of monocytes/macrophages to pathologic concentrations of Co2+ significantly impaired both phenotype and functionality. High concentrations of Co2+ induced loss of surface markers, including CD14 and CD16. Both Co2+ and Cr3+ impaired macrophage responses to Staphylococcus aureus infection. Co2+ -exposed macrophages, in particular, showed decreased phagocytic activity. These findings demonstrate the immunosuppressive effects of locally elevated metal ions on the innate immune response. Streptococcus pyogenes (group A streptococcus, GAS) causes a variety of diseases ranging from mild to severe necrotizing soft tissue infections (NSTIs). In the host environment hypervirulent GAS variants carrying mutations within the genes encoding for control of virulence (Cov)R/S two component system are enriched. This adaptation is associated with loss of SpeB secretion. In Paper II, we show that in vitro infections with hyper-virulent GAS variants harboring dysfunctional CovR/S suppress secretion of IL-8 and IL-18 by human monocytic cells. This phenotype was mediated by a caspase-8 dependent mechanism. Knockout of streptococcal SLO in a GAS strain carrying functional CovR/S even increased secretion of IL1β and IL-18 by moDCs. Of 67 fully sequenced GAS NSTI isolates, 28 contained covS or covR mutations that rendered the TCS dysfunctional. However, no differences in systemic IL-8 and IL-18 were detected in these patients. GAS isolates recovered from patients often display a mixed phenotype, consisting of SpeB positive (SpeB+ ) and SpeB negative (SpeB- ) clones. Irreversible loss of SpeB expression is often caused by loss of function mutations in regulatory components (CovR/S, RopB). Loss of SpeB is often associated with hyper-virulence. In Paper III, we show that the host environment induces transiently abrogated secretion of SpeB by GAS. Tissue inflammation, neutrophil influx, and degranulation correlated with increased frequencies of SpeB- GAS clones. Isolates recovered from tissue expressed but did not secrete SpeB, which was reversible. Neutrophilderived ROS were identified as the main factor responsible for abrogated SpeB secretion. Hyper-virulent SpeB- clones also exhibit better survival within and induce excessive degranulation of neutrophils.